Dr. Paggiarino has previously held several executive positions in the area of ophthalmology for companies including Alcon, Pfizer Global R&D and Pharmacia Global.
Lpath is currently developing drugs for wet macular degeneration and renal cell carcinoma patients.
More Articles on Ophthalmology:
3 Statistics on Cataract Surgery Procedure Times in ASCs
New York Medical Society Names Dr. Sam Unterricht President
Study Finds Optomap Increases Retinal Lesion Detection
